Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
iason.vichos@ndm.ox.ac.uk

Research groups

Gonococcal Vaccine Project

Iason Vichos

Senior Project Manager

Recent publications

Consultation report - gonococcal immunoassays and standards for vaccine development.

MacLennan CA. et al, (2026), Vaccine, 86

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

Ratcliffe H. et al, (2023), iScience, 26, 108500 - 108500

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021

Ratcliffe H. et al, (2023), Archives of Disease in Childhood, 108, 123 - 130

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

Shaw RH. et al, (2022), The Lancet Respiratory Medicine, 10, 1049 - 1060

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

Stuart ASV. et al, (2022), The Lancet, 399, 36 - 49